Pontifax IV, 10% Owner of Keros Therapeutics KROS, has filed 0 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $85M. The latest trade was on 25/10/15.

PI

PI

Pontifax IV

10% Owner

Company

Keros Therapeutics KROS

First filing

25/10/17

Trades

4 trades

Buys / sales

0 / 4

12-month net buying

−$85M

Last trade

25/10/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Keros TherapeuticsKROS	Open-market sale	25/10/15	25/10/17	4,787,331 sh4 trades	$17.75avg.	$84,975,125.25	−100.0%